Skip to main content

TTK Healthcare Ltd

Stage 2 · Advancing · week 8Setup 4.0 WatchSolid +1.0

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. More about the company

₹1,046.6
+1.25% today
₹1,479 Cr · Small cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-12.2%
₹739.6 lo₹1,192.6 hi
12.2% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 8
1w13w26w
Week 8 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
8.4%
200 DMA: ₹965.2 · sloping down
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.33x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -3.7% vs MA50 +3.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-4.9%
3M
+14.6%
6M
+32.9%
YTD
+1.0%
1Y
-7.9%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #66 of 77 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #52 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 30w
S4 23w
S4 41w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 1w → S2 3w → S3 12w → S2 30w → S3 10w → S2 13w → S3 6w → S4 23w → S1 12w → S4 41w → S1 10w → S2 8w current
Total tracked: 169 weeks across 13 stage runs.
Scan Membership
Prop Scan
Latest: 2026-09-15
Breakout Watch
Latest: 2026-08-13
25 appearances in last 60 days. First seen: 2024-08-08.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 8 · Vol 0.33x
2026-10-06S2
Wk 8 · Vol 0.54x
2026-10-05S2
Wk 8 · Vol 0.43x
2026-10-01S2
Wk 7 · Vol 0.26x
2026-09-30S2
Wk 7 · Vol 0.18x
2026-09-29S2
Wk 7 · Vol 0.24x
2026-09-28S2
Wk 7 · Vol 0.39x
2026-09-25S2
Wk 7 · Vol 0.28x
2026-09-24S2
Wk 6 · Vol 0.27x
2026-09-23S2
Wk 6 · Vol 0.56x
2026-09-22S2
Wk 6 · Vol 0.66x
2026-09-21S2
Wk 6 · Vol 0.65x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹1,080.4
200 DMA
₹965.2
52W High
₹1,192.6
52W Low
₹739.6
5D Low
₹1,007.4
Resistance levels (recent highs)
20d High
₹1,191
60d High
₹1,191
120d High
₹1,191
250d High
₹1,192.6
Next resistance
+13.8%
to 20d High
P/E (TTM)
21.0
Forward —
Earnings Growth (YoY)
-37.1%
Revenue +2.2%
Dividend Yield
1.14%
P/B 1.2
About this companyHealth Care· Pharmaceuticals

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripe water name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.